WO2004099231A2
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
DE10209821A1
(en)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Coupling of proteins to a modified polysaccharide
|
DE10209822A1
(en)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Coupling of low molecular weight substances to a modified polysaccharide
|
KR101045422B1
(en)
|
2002-09-11 |
2011-06-30 |
프레제니우스 카비 도이치란트 게엠베하 |
Method of producing hydroxyalkyl starch derivatives
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
CA2547140A1
(en)
*
|
2003-11-24 |
2005-06-09 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
DE202005021885U1
(en)
|
2004-03-11 |
2011-03-03 |
Fresenius Kabi Deutschland Gmbh |
Hydroxyalkyl starch-protein conjugates prepared by reductive amination
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
PL2586456T3
(en)
|
2004-10-29 |
2016-07-29 |
Ratiopharm Gmbh |
Remodeling and glycopegylation of fibroblast growth factor (FGF)
|
NZ555308A
(en)
|
2004-12-22 |
2010-10-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
EP2514757A3
(en)
|
2005-01-10 |
2014-03-05 |
ratiopharm GmbH |
Glycopegylated granulocyte colony stimulating factor
|
EP1871795A4
(en)
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
EP1954710B1
(en)
|
2005-11-08 |
2011-03-02 |
Ambrx, Inc. |
Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
|
CN101448512B
(en)
|
2005-12-14 |
2015-11-25 |
Ambrx公司 |
Purposes containing alpha-non-natural amino acid and the compositions of polypeptide, the method relating to alpha-non-natural amino acid and polypeptide and alpha-non-natural amino acid and polypeptide
|
US9187532B2
(en)
|
2006-07-21 |
2015-11-17 |
Novo Nordisk A/S |
Glycosylation of peptides via O-linked glycosylation sequences
|
US20100075375A1
(en)
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
KR20150064246A
(en)
|
2007-04-03 |
2015-06-10 |
바이오제너릭스 게엠베하 |
Methods of treatment using glycopegylated g―csf
|
EP2170919B8
(en)
|
2007-06-12 |
2016-01-20 |
ratiopharm GmbH |
Improved process for the production of nucleotide sugars
|
EP2070950A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkyl starch derivatives and process for their preparation
|
WO2009108806A1
(en)
|
2008-02-27 |
2009-09-03 |
Novo Nordisk A/S |
Conjugated factor viii molecules
|